IL-17 and IL-11 GCF levels in aggressive and chronic periodontitis patients: relation to PCR bacterial detection.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 3513783)

Published in Mediators Inflamm on November 26, 2012

Authors

Olfat G Shaker1, Noha A Ghallab

Author Affiliations

1: Department of Medical Biochemistry & Molecular Biology, Faculty of Medicine, Cairo University, Egypt. olfatshaker@yahoo.com

Articles cited by this

Microbial complexes in subgingival plaque. J Clin Periodontol (1998) 15.90

PERIODONTAL DISEASE IN PREGNANCY. II. CORRELATION BETWEEN ORAL HYGIENE AND PERIODONTAL CONDTION. Acta Odontol Scand (1964) 15.31

Development of a classification system for periodontal diseases and conditions. Ann Periodontol (1999) 12.48

Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity (2006) 10.53

T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med (1996) 8.59

Microbial etiological agents of destructive periodontal diseases. Periodontol 2000 (1994) 5.49

Survival of human dental plaque flora in various transport media. Appl Microbiol (1972) 4.88

Anti-inflammatory cytokines. Chest (2000) 4.74

Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. Biochem Biophys Res Commun (2000) 2.14

A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. J Dent Res (2008) 2.05

Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment. J Leukoc Biol (2004) 2.03

IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance. J Immunol (2003) 1.78

Proinflammatory cytokines in CRP baseline regulation. Adv Clin Chem (2009) 1.68

Host response modulation in the management of periodontal diseases. J Clin Periodontol (2005) 1.47

Levels of interleukin-17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis. J Clin Periodontol (2005) 1.40

The involvement of IL-23 and the Th17 pathway in periodontitis. J Dent Res (2009) 1.26

Comparison of neutrophil functions in aggressive and chronic periodontitis. Periodontol 2000 (2010) 1.25

Comparison of the microbiological features of chronic and aggressive periodontitis. Periodontol 2000 (2010) 1.22

MMPs, IL-1, and TNF are regulated by IL-17 in periodontitis. J Dent Res (2007) 1.21

Interleukin-11 and IL-17 and the pathogenesis of periodontal disease. J Periodontol (2004) 1.18

Induction of the immune response to periodontopathic bacteria and its role in the pathogenesis of periodontitis. Periodontol 2000 (1997) 1.15

Serum levels of cytokines in subjects with generalized chronic and aggressive periodontitis before and after non-surgical periodontal therapy: a pilot study. J Periodontol (2010) 1.14

Interleukin-11 as a stimulatory factor for bone formation prevents bone loss with advancing age in mice. J Biol Chem (2002) 1.13

The potential role of interleukin-17 in the immunopathology of periodontal disease. J Clin Periodontol (2005) 1.13

Porphyromonas gingivalis antigen preferentially stimulates T cells to express IL-17 but not receptor activator of NF-kappaB ligand in vitro. Oral Microbiol Immunol (2003) 1.12

Microbiological profile of untreated subjects with localized aggressive periodontitis. J Clin Periodontol (2009) 1.04

Balance of inflammatory response in stable gingivitis and progressive periodontitis lesions. Clin Exp Immunol (2006) 1.02

Gingival concentrations of interleukin-23 and -17 at healthy sites and at sites of clinical attachment loss. J Periodontol (2007) 0.97

IL-17 in sera from patients with aggressive periodontitis. J Dent Res (2010) 0.94

The effect of interleukin-11 on the progression of ligature-induced periodontal disease in the beagle dog. J Periodontol (2000) 0.93

Interleukin-11, interleukin-1beta, interleukin-12 and the pathogenesis of inflammatory periodontal diseases. J Clin Periodontol (2008) 0.92

Serum cytokine levels in periodontitis patients in relation to the bacterial load. J Periodontol (2010) 0.91

Effect of interleukin-17 on nitric oxide production and osteoclastic bone resorption: is there dependency on nuclear factor-kappaB and receptor activator of nuclear factor kappaB (RANK)/RANK ligand signaling? Bone (2001) 0.91

Advances in the pathogenesis of periodontitis. Group B consensus report of the fifth European Workshop in Periodontology. J Clin Periodontol (2005) 0.89

The impact of the IL-11:IL-17 ratio on the chronic periodontitis pathogenesis: a preliminary report. Oral Dis (2008) 0.82

Decreased interleukin-2 responses to Fusobacterium nucleatum and Porphyromonas gingivalis in generalized aggressive periodontitis. J Periodontol (2009) 0.81

Synergism between interleukin-11 and bone morphogenetic protein-2 in the healing of segmental bone defects in a rabbit model. J Interferon Cytokine Res (2004) 0.78